Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03107585
Other study ID # CBTCpood
Secondary ID
Status Completed
Phase N/A
First received January 13, 2016
Last updated April 4, 2017
Start date January 2015
Est. completion date January 2016

Study information

Verified date April 2017
Source University Hospital, Mahdia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators included prospectively 35 patients undergoing an intermediate cervical block under ultrasound (GP1) before a thyroidectomy ,compared to a group of 35 patients without a block (GP2).


Description:

The investigators performed prospective trial with 70 patients randomized in two groups each of 35:

- Group 1 (GP1): bilateral echo-guided intermediate cervical plexus bloc (ICB) by 10 ml of isobaric Bupivacaine (0.25%).

- Group 2 (GP2): control.

Ten minutes after ICB, general anesthesia was realised. Total dose of Remifentanil is calculated upon awakening, the postoperative pain is determined by visual analog scale from 0 to 10 (VAS) statements to H0, H2, H4, H6, H12 and H24. Whenever VAS is greater than or equal to 4, a morphine titration was administered.

Total dose consumption, side effects and satisfaction are noted at the end of protocol.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- candidate for thyroidectomy

- reoperation l

Exclusion Criteria:

- no consent

- BMI> 34

- allergy to any of the products used

- reoperation

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
bilateral cervical plexus block
with a linear probe and after disinfection vascular neck axis are identified at first. At the cricoid cartilage we conducted an apical scan to locate the carotid bifurcation.at this level is carried out a lateral translation to the visibility of the deep cervical space below the sternocleidomastoidien muscle then a needle 50 is introduced in plane. we proceed in inundation of cervical space

Locations

Country Name City State
Tunisia Mahdia University Hospital Mahdia

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Mahdia

Country where clinical trial is conducted

Tunisia, 

Outcome

Type Measure Description Time frame Safety issue
Primary peroperative opioid consumption In addition to the standard monitoring , we associate that of narcosis (BIS, Covidien LLC.Mansfield, USA) whose level is maintained between 40 and 60, a monitoring of the capnia, maintained between 35 and 40mmHg, we associate an analyzer of gas.The maintenance of the anesthesia is provided by sevoflurane adjusted according to the values of the bi-spectral index. Remifentanil is administered by the electrical pump as a function of the variation in blood pressure and heart rate, which should not exceed 20% of their baseline values during the surgical procedure.All our patients were operated by the same team.
Ten minutes before closure, each patient receives 1 g of paracetamol (Perfalgan®) and 50 to 100 mg of tramadol depending on his weight. The remifentanil syringe pump is stopped when the skin is closed and the total dose is calculated for each patient.
opioid consumption during surgery
Secondary postoperative opioid consumption the investigator proceed to evaluate pain at H0, H2, H4, H6, H12 and H24 postoperative hour. Each time the patient had a Visual analogic scale (VAS) greater than or equal to 40mm(from 0 to 100) a titration of 3 mg intravenous morphine every 5 minutes until VAS <40mm . Total dose of morphine required was calculated 24 hours after surgery first 24 hours after surgery
See also
  Status Clinical Trial Phase
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Completed NCT03262857 - Effect of Lidocaine With Magnesium Sulfate on the Success of the Inferior Alveolar Nerve Block Phase 2
Withdrawn NCT03502135 - Efficacy of Tetracaine/Oxymetazoline Nasal Spray for Endodontic Treatment Phase 4
Not yet recruiting NCT02535273 - The Effect of Dexmedetomidine Analgesia and Sedation in Minimally Invasive Spine Surgery Under Local Anesthesia Phase 4
Not yet recruiting NCT05902780 - Can Caudal Dexmedetomidine Provide Effective Analgesia? N/A
Completed NCT04885777 - Topical Lidocaine Anesthesia for Nasopharyngeal Sampling N/A
Recruiting NCT04086394 - PECS Block in Partial Mastectomy for Postoperative Pain Control N/A
Recruiting NCT06129162 - Pain Perception Comparison of Computerized vs Conventional Injection Methods N/A
Completed NCT02922504 - Impact of Music Intervention on Pain Control In First Trimester Surgical Abortion Under Local Anesthesia N/A
Completed NCT00539084 - A Study to Assess the Safety and Efficacy of a Microneedle Device for Local Anesthesia N/A
Completed NCT03176446 - Pain and Anxiety Evaluation in Children Using Different Techniques of Local Anesthesia for Dental Treatment N/A
Completed NCT04947267 - To Compare the Pulpal Oxygen Saturation Level After Administering Mepivacaine With and Without Vasoconstrictor Phase 2
Completed NCT02825225 - A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes N/A
Completed NCT01360749 - Efficacy and Safety of Lambdalina (Lidocaine Cream) Versus Placebo as an Anesthetic for Laser Hair Removal Phase 2
Completed NCT00889642 - Safety and Efficacy Study of an Iontophoretic Patch Containing Lidocaine and Epinephrine for Venipuncture in Healthy Adult Volunteers Phase 2
Not yet recruiting NCT06395987 - Result Of Use Of Wide Awake Local Anaesthesia In Fixation Of Ankle Fractures
Active, not recruiting NCT05473819 - Effectiveness of Sodium Bicarbonate Buffered Anaesthetic Solution on Pain During Injection N/A
Completed NCT04653974 - Pain Perception of Needle-free System N/A
Completed NCT02884596 - Success of Inferior Alveolar Nerve Block in Women Taking Selective Serotonin Reuptake Inhibitors
Completed NCT02440347 - Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block Phase 4